Evidence map›Paper›PMID 32913655›Full record

ArticleCanadian journal of kidney health and disease2020

Case Report: Segmental Arterial Mediolysis, a Rare Cause of Hypertension.

Jieqing Jessica Xu, Pasteur Rasuli, Kevin D Burns

Open access · goldAbstract readCase Reports
In one paragraph

Article in Canadian journal of kidney health and disease, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 83% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Jieqing Jessica XuDepartment of Medicine, The Ottawa Hospital, University of Ottawa, ON, Canada.
Pasteur RasuliDepartment of Radiology, Division of Angiography and Interventional Radiology, The Ottawa Hospital, University of Ottawa, ON, Canada.
Kevin D BurnsDivision of Nephrology, Department of Medicine, The Ottawa Hospital, University of Ottawa, ON, Canada.ORCID https://orcid.org/0000-0002-1482-5826
University of Ottawa · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

rationaleThe differential diagnosis for hypertension with elevated plasma renin is broad. This case illustrates one of the rarer, and therefore underrecognized, causes of high renin hypertension. PRESENTING CONCERNS OF THE PATIENT: A 41-year-old man with a medical history significant for multiple ischemic strokes and dyslipidemia presented for assessment of decreased renal function and resistant hypertension. His initial workup for secondary causes of hypertension was remarkable for an elevated plasma renin and normal aldosterone. Further investigation with computed tomography (CT) angiography was performed, which demonstrated multiple bilateral renal aneurysms and infarcts. DIAGNOSES: After ruling out other potential causes of bilateral renal aneurysms and infarcts, a diagnosis of segmental arterial mediolysis (SAM) was made.

interventionsOptimization of antihypertensive regimen, counseling regarding regular home blood pressure monitoring, and smoking cessation. OUTCOMES: The patient achieved excellent blood pressure control, stable renal function, and had no further strokes or other vascular events. TEACHING POINTS: Our case demonstrates the importance of considering SAM in the diagnosis of hypertension with elevated plasma renin and as a vasculitis mimic. It also highlights the importance of considering renal vascular imaging in the workup of resistant hypertension.

Indexed as

renal infarctsreninrenovascular hypertensionsecondary hypertensionsegmental arterial mediolysis

Identifiers

PMID32913655
PMCPMC7444149
OpenAlexW3081502912

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.